BRIEF

on VALBIOTIS (EPA:ALVAL)

Valbiotis launches a prevention campaign against cardiometabolic risks in women.

Stock price chart of VALBIOTIS (EPA:ALVAL) showing fluctuations.

Valbiotis, a French laboratory specializing in cardiometabolic health, has announced the launch of the "Heart at Stake" campaign to raise awareness of cardiometabolic risks in women, with the support of the Agir pour le Cœur des Femmes Foundation. Cardiovascular diseases represent a significant threat, especially after menopause.

This campaign aims to inform about the relationship between hormones and cardiometabolic health, raise awareness of the consequences of lifestyle, and support women in better managing their health. It incorporates interventions from healthcare professionals and educational tools.

Available until June, this initiative includes the participation of public figures and media partnerships to maximize impact and enhance the visibility of Valbiotis.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all VALBIOTIS news